PL179857B1 - Pochodne kwasu 2-amino-4-fenylo-4-okso-maslowego, sposób ich wytwarzania oraz zawierajaca je kompozycja farmaceutyczna PL PL PL PL PL PL - Google Patents
Pochodne kwasu 2-amino-4-fenylo-4-okso-maslowego, sposób ich wytwarzania oraz zawierajaca je kompozycja farmaceutyczna PL PL PL PL PL PLInfo
- Publication number
- PL179857B1 PL179857B1 PL94308142A PL30814294A PL179857B1 PL 179857 B1 PL179857 B1 PL 179857B1 PL 94308142 A PL94308142 A PL 94308142A PL 30814294 A PL30814294 A PL 30814294A PL 179857 B1 PL179857 B1 PL 179857B1
- Authority
- PL
- Poland
- Prior art keywords
- formula
- compound
- amino
- group
- oxo
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C259/00—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
- C07C259/04—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids
- C07C259/06—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids having carbon atoms of hydroxamic groups bound to hydrogen atoms or to acyclic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/34—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton containing six-membered aromatic rings
- C07C229/36—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton containing six-membered aromatic rings with at least one amino group and one carboxyl group bound to the same carbon atom of the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
- C07C237/20—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton containing six-membered aromatic rings
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurology (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Emergency Medicine (AREA)
- Hematology (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Diabetes (AREA)
- Hospice & Palliative Care (AREA)
- Obesity (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Enzymes And Modification Thereof (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT93MI001649A IT1265101B1 (it) | 1993-07-23 | 1993-07-23 | Derivati dell'acido 2-ammino-4-fenil-4-osso butirrico |
| PCT/EP1994/002280 WO1995003271A1 (en) | 1993-07-23 | 1994-07-12 | 2-amino-4-phenyl-4-oxo-butyric acid derivatives with kynureninase and/or kynurenine-3-hydroxylase inhibiting activity |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| PL308142A1 PL308142A1 (en) | 1995-07-24 |
| PL179857B1 true PL179857B1 (pl) | 2000-11-30 |
Family
ID=11366678
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL94308142A PL179857B1 (pl) | 1993-07-23 | 1994-07-12 | Pochodne kwasu 2-amino-4-fenylo-4-okso-maslowego, sposób ich wytwarzania oraz zawierajaca je kompozycja farmaceutyczna PL PL PL PL PL PL |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US20010008947A1 (OSRAM) |
| EP (1) | EP0662948B1 (OSRAM) |
| JP (1) | JPH08501805A (OSRAM) |
| KR (1) | KR950703517A (OSRAM) |
| CN (1) | CN1112786A (OSRAM) |
| AT (1) | ATE171935T1 (OSRAM) |
| AU (1) | AU678273B2 (OSRAM) |
| CA (1) | CA2144521A1 (OSRAM) |
| DE (1) | DE69413789T2 (OSRAM) |
| DK (1) | DK0662948T3 (OSRAM) |
| ES (1) | ES2123801T3 (OSRAM) |
| FI (1) | FI951298L (OSRAM) |
| HU (1) | HUT70478A (OSRAM) |
| IL (1) | IL110365A (OSRAM) |
| IT (1) | IT1265101B1 (OSRAM) |
| NZ (1) | NZ268896A (OSRAM) |
| PL (1) | PL179857B1 (OSRAM) |
| RU (1) | RU2139850C1 (OSRAM) |
| TW (1) | TW268937B (OSRAM) |
| WO (1) | WO1995003271A1 (OSRAM) |
| ZA (1) | ZA945425B (OSRAM) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5519055A (en) * | 1993-08-06 | 1996-05-21 | University Of Maryland At Baltimore | Substituted kynurenines and process for their preparation |
| US5786508A (en) * | 1994-07-15 | 1998-07-28 | Pharmacia & Upjohn S.P.A. | Substituted kynurenines and process for their preparation |
| GB9521486D0 (en) * | 1995-10-20 | 1995-12-20 | Pharmacia Spa | Fluoro-substituted benzoylpropionic acid derivatives |
| GB9615441D0 (en) * | 1996-07-23 | 1996-09-04 | Pharmacia Spa | Benzoylpropionic acid ester derivatives |
| ATE282602T1 (de) * | 1996-08-16 | 2004-12-15 | Warner Lambert Co | Buttersäure matrix-metalloproteinase-inhibitoren |
| GB9618349D0 (en) * | 1996-09-03 | 1996-10-16 | Pharmacia Spa | N-substituted 2-amino-4-phenyl-4-oxo-butanoic acid derivatives with kynurenine-3-hydroxylase inhibitory activity |
| GB9716103D0 (en) * | 1997-07-30 | 1997-10-01 | Pharmacia & Upjohn Spa | Condensed heterocyclic compounds |
| GB9725055D0 (en) * | 1997-11-26 | 1998-01-28 | Pharmacia & Upjohn Spa | 1,3,4-thiadiazoles compounds |
| GB9725141D0 (en) * | 1997-11-27 | 1998-01-28 | Pharmacia & Upjohn Spa | Benzenesulfonamide compounds |
| JP5627160B2 (ja) * | 1998-02-23 | 2014-11-19 | サウス、アラバマ、メディカル、サイエンス、ファウンデーションＳｏｕｔｈ Ａｌａｂａｍａ Ｍｅｄｉｃａｌ Ｓｃｉｅｎｃｅ Ｆｏｕｎｄａｔｉｏｎ | 医薬として用いるインドール−３−プロピオン酸、並びにそれらの塩およびエステル |
| US6783965B1 (en) * | 2000-02-10 | 2004-08-31 | Mountain View Pharmaceuticals, Inc. | Aggregate-free urate oxidase for preparation of non-immunogenic polymer conjugates |
| ATE288414T1 (de) * | 1998-11-11 | 2005-02-15 | Novartis Pharma Gmbh | Herstellung von 2-amino-2(2-(4- alkylphenyl)äthyl)propan-1,3-diolen |
| CN1144779C (zh) * | 1999-03-11 | 2004-04-07 | 杭州中美华东制药有限公司 | 制备2-[2-(4-烷基苯基)-乙基]-2-氨基-丙二醇的方法以及其中制得的中间产物 |
| KR100965201B1 (ko) * | 2001-06-12 | 2010-06-24 | 웰스테트 테라퓨틱스 코포레이션 | 대사 질환의 치료용 화합물 |
| FR2827045B1 (fr) * | 2001-07-05 | 2007-08-10 | Univ Pasteur | Methodes et compositions pour la selection et le developpement de nouveaux agents pharmacologiques ou de nouveaux medicaments |
| FR2827859B1 (fr) | 2001-07-30 | 2005-09-23 | Lipha | Derives 4-(arylthio) - ou 4-(heteroarylthio) -butyrique dans la preparation de medicaments destines au traitement du diabete |
| CN1330774C (zh) * | 2002-03-01 | 2007-08-08 | 国家人类基因组南方研究中心 | 犬尿氨酸水解酶多态性及其用途 |
| ITMI20041626A1 (it) * | 2004-08-06 | 2004-11-06 | Roberto Pellicciari | Inibitori della chinurenina-ammino-trasferasi |
| CN1309702C (zh) * | 2005-10-28 | 2007-04-11 | 中国科学院上海有机化学研究所 | 犬尿氨酸酶的特异性抑制剂l－邻甲氧基苯甲酰基丙氨酸的合成方法 |
| AU2009226975B2 (en) | 2008-03-19 | 2012-09-06 | Novartis Ag | Process for the preparation of 2-amino-2- [2- (4-C3-C21-alkyl-phenyl)ethyl] propane-1, 3-diols |
| EP3197466B1 (en) * | 2014-09-26 | 2021-02-17 | The University Of British Columbia | A combination of kynurenine and antigen presenting cells (apc) as therapeutics and methods for their use in immune modulation |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FI96313C (fi) * | 1990-11-28 | 1996-06-10 | Daiichi Seiyaku Co | Menetelmä terapeuttisesti käyttökelpoisten ja optisesti aktiivisten 10-(3-amino-4,4-dialkyyli-1-pyrrolidinyyli)-9-fluori-2,3-dihydro-3(S)-metyyli-7-okso-7H-pyrido/1,2,3-de//1,4/bentsoksatsiini-6-karboksyylihappojen valmistamiseksi |
| AU643365B2 (en) * | 1991-02-28 | 1993-11-11 | Aventisub Ii Inc. | NMDA antagonists |
| EP0581907A1 (en) * | 1991-04-18 | 1994-02-09 | The University Of Georgia Research Foundation, Inc. | Inhibitors of kynureninase |
| US5495044A (en) * | 1991-04-18 | 1996-02-27 | University Of Georgia Research Foundation, Inc. | Inhibitors of kynureninase |
| GB9325360D0 (en) * | 1993-12-10 | 1994-02-16 | Univ Bristol | Organic compounds |
-
1993
- 1993-07-23 IT IT93MI001649A patent/IT1265101B1/it active IP Right Grant
-
1994
- 1994-07-12 AU AU72285/94A patent/AU678273B2/en not_active Ceased
- 1994-07-12 PL PL94308142A patent/PL179857B1/pl unknown
- 1994-07-12 DK DK94921642T patent/DK0662948T3/da active
- 1994-07-12 CA CA002144521A patent/CA2144521A1/en not_active Abandoned
- 1994-07-12 KR KR1019950701103A patent/KR950703517A/ko not_active Abandoned
- 1994-07-12 HU HU9501146A patent/HUT70478A/hu unknown
- 1994-07-12 WO PCT/EP1994/002280 patent/WO1995003271A1/en not_active Ceased
- 1994-07-12 AT AT94921642T patent/ATE171935T1/de not_active IP Right Cessation
- 1994-07-12 NZ NZ268896A patent/NZ268896A/en unknown
- 1994-07-12 ES ES94921642T patent/ES2123801T3/es not_active Expired - Lifetime
- 1994-07-12 FI FI951298A patent/FI951298L/fi unknown
- 1994-07-12 CN CN94190531A patent/CN1112786A/zh active Pending
- 1994-07-12 JP JP7503289A patent/JPH08501805A/ja active Pending
- 1994-07-12 RU RU95111308A patent/RU2139850C1/ru active
- 1994-07-12 EP EP94921642A patent/EP0662948B1/en not_active Expired - Lifetime
- 1994-07-12 DE DE69413789T patent/DE69413789T2/de not_active Expired - Fee Related
- 1994-07-19 IL IL110365A patent/IL110365A/en not_active IP Right Cessation
- 1994-07-21 TW TW083106674A patent/TW268937B/zh active
- 1994-07-22 ZA ZA945425A patent/ZA945425B/xx unknown
-
1997
- 1997-10-14 US US08/949,392 patent/US20010008947A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| EP0662948A1 (en) | 1995-07-19 |
| ES2123801T3 (es) | 1999-01-16 |
| PL308142A1 (en) | 1995-07-24 |
| DE69413789D1 (de) | 1998-11-12 |
| AU678273B2 (en) | 1997-05-22 |
| ATE171935T1 (de) | 1998-10-15 |
| FI951298A0 (fi) | 1995-03-20 |
| WO1995003271A1 (en) | 1995-02-02 |
| IL110365A (en) | 1998-06-15 |
| JPH08501805A (ja) | 1996-02-27 |
| CA2144521A1 (en) | 1995-02-02 |
| HUT70478A (en) | 1995-10-30 |
| ITMI931649A0 (it) | 1993-07-23 |
| NZ268896A (en) | 1997-01-29 |
| HU9501146D0 (en) | 1995-06-28 |
| TW268937B (OSRAM) | 1996-01-21 |
| RU2139850C1 (ru) | 1999-10-20 |
| FI951298A7 (fi) | 1995-03-20 |
| KR950703517A (ko) | 1995-09-20 |
| IT1265101B1 (it) | 1996-10-30 |
| ITMI931649A1 (it) | 1995-01-23 |
| DE69413789T2 (de) | 1999-05-06 |
| IL110365A0 (en) | 1994-10-21 |
| DK0662948T3 (da) | 1999-06-21 |
| ZA945425B (en) | 1995-03-01 |
| EP0662948B1 (en) | 1998-10-07 |
| RU95111308A (ru) | 1996-12-27 |
| AU7228594A (en) | 1995-02-20 |
| FI951298L (fi) | 1995-03-20 |
| CN1112786A (zh) | 1995-11-29 |
| US20010008947A1 (en) | 2001-07-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0662948B1 (en) | 2-amino-4-phenyl-4-oxo-butyric acid derivatives with kynureninase and/or kynurenine-3-hydroxylase inhibiting activity | |
| CA2156024C (en) | Synthetic excitatory amino acids | |
| EP0737671A2 (en) | Aromatic hydroxamic acid compounds, their production and use | |
| CA2520611A1 (en) | Hydroxamic acid compounds and methods of use thereof | |
| KR20040017812A (ko) | 심장병 환자 및 대사 장애를 위한 갑상선 호르몬 수용체길항근ⅱ | |
| FR2606018A1 (fr) | Nouveaux a-aminoacides substitues, leur preparation et leur utilisation en therapeutique comme medicaments | |
| JP2000511872A (ja) | キヌレニン−３−ヒドロキシラーゼ阻害活性を有する４−フェニル−４−オキソ−２−ブテン酸誘導体 | |
| WO2012008785A2 (ko) | 라말린의 합성방법 | |
| NZ250580A (en) | 3-(hetero)aryloxymorphinan derivatives and their use in the manufacture of medicaments | |
| US6207709B1 (en) | N-substituted-2-amino-4-phenyl-4-oxo-butanoic acid compounds having kynurenine-3-hydroxy base inhibitory activity | |
| CA2083307A1 (en) | Aminoalkanephosphinic acids and salts thereof | |
| HU215436B (hu) | Eljárás N-[(4,5-dihidroxi-9,10-dihidro-9,10-dioxo-2-antracenil)-karbonil]-aminosav-származékok és ilyen hatóanyagot tartalmazó gyógyszerkészítmények előállítására | |
| EP0862551B1 (en) | Fluoro-substituted benzoylpropionic acid derivatives | |
| JPH05201984A (ja) | キノリニ−２−ル−メトキシベンジルヒドロキシ尿素類 | |
| US5883129A (en) | Hydroxylated anthranilic acid derivatives | |
| JP2008509105A (ja) | キヌレニン−アミノトランスフェラーゼ阻害剤として有用な４−スルホニル−置換ベンゾイルアラニン誘導体 | |
| HU187429B (en) | Process for preparing benzylidine derivatives and medical preparatives containing such compounds | |
| CA2258074A1 (en) | Benzoylpropionic acid ester derivatives | |
| JPS61191611A (ja) | ド−パミン受容体刺激剤 | |
| HU219346B (en) | N-[(4,5-dihydroxi-9,10-dihydro-9,10-dioxo-2-anthracenyl)-carbonyl]-amino acids and pharmaceutical compositions containing the same |